×
About 658,103 results

Conjunctivitis Treatment Protocols Lack Uniformity Across the US
https://www.clinicaladvisor.com/home/topics/ophthalmology-information-center/acute-conjunctivitis-treatments-are-inconsistent-between-pediatric-practices/
Clinical Advisor

Mar 31st, 2023 - Diagnosing and treating infectious conjunctivitis is relatively routine, but the costs to the family and society can be significant. Currently, no uniform conjunctivitis treatment protocols for managing acute infectious conjunctivitis in children exist, and according to the American Academy of Pediatrics, the role of antibiotics is unclear.1-3 Acute conjunctivitis — an eye condition most common...

The physician as leader
https://www.mdedge.com/obgyn/article/262155/business-medicine/physician-leader
Mark P. Trolice MD, MBA

Mar 31st, 2023 - Physicians are placed in positions of leadership by the medical team, by the community, and by society, particularly during times of crisis such as the COVID pandemic. They are looked to by the media at times of health care news such as the overturning of Roe v.

Aspirin Use and Bone Health: Unpacking the Controversy
https://www.clinicaladvisor.com/home/topics/rheumatology-information-center/aspirin-use-and-bone-health-unpacking-the-controversy/
Clinical Advisor

Mar 31st, 2023 - For decades, daily low-dose aspirin has been recommended to prevent the development of cardiovascular disease and reduce the risk for myocardial infarction or stroke in middle-aged and older adults. However, the benefits of daily aspirin use are now being questioned as research has revealed potential detriments of the prophylactic treatment, particularly among those at increased risk for falls,...

Brains Shrink With Anti-Amyloid Alzheimer's Drugs
https://www.medpagetoday.com/neurology/alzheimersdisease/103817

Mar 31st, 2023 - Anti-amyloid therapies for Alzheimer's disease accelerated brain atrophy, a systematic review and meta-analysis of MRI data showed. Across 31 clinical trials, brain volume changes were seen for different classes of anti-amyloid agents, reported Scott Ayton, PhD, of the University of Melbourne in Australia, and co-authors in Neurology. The analysis focused mainly on two types of anti-amyloid dru...

Premedical Student Interest in and Exposure to Dermatology at Howard University
https://www.mdedge.com/dermatology/article/262152/mixed-topics/premedical-student-interest-and-exposure-dermatology-howard
Geeta Ahuja, MD, Nnaemeka C. Okorie, MD et. al.

Mar 31st, 2023 - Diversity of health care professionals improves medical outcomes and quality of life in patients. 1 There is a lack of diversity in dermatology, with only 4.

Expect increased demand for experienced dermatologic care of Asian skin
https://www.mdedge.com/dermatology/article/262150/diversity-medicine/expect-increased-demand-experienced-dermatologic-care
Doug Brunk

Mar 31st, 2023 - NEW ORLEANS – With the Asian population estimated to increase to 41 million by 2050 in the United States, expect the demand for experienced dermatologic care of patients with Asian skin to increase in the coming years, Hye Jin (Leah) Chung, MD, said at the annual meeting of the American Academy of Dermatology. “Asians account for about 60% of the global population,” said Dr.

Subcutaneous Panniculitic T-cell Lymphoma Presenting With Anasarca in a Patient With Known Chronic Lymphocytic Leukemia
https://www.mdedge.com/dermatology/article/262149/nonmelanoma-skin-cancer/subcutaneous-panniculitic-t-cell-lymphoma
Lauren Reinhold, DO, Peter Neidenbach, MD

Mar 31st, 2023 - To the Editor: Subcutaneous panniculitic T-cell lymphoma (SPTCL) is a rare cutaneous T-cell lymphoma that was first described in 19911 and comprises less than 1% of all non-Hodgkin lymphomas (NHLs). It most commonly occurs in young adults, with a median patient age of 36 years and a slight female predominance.

Sleep, Exercise, and Death; Pope Improving, Eats Pizza; Obesity Med Strategies
https://www.medpagetoday.com/primarycare/sleepdisorders/103806

Mar 31st, 2023 - Note that some links may require subscriptions. Higher levels of physical activity may diminish the mortality risk associated with poor sleep, according to findings from the U.K. Biobank. (European Journal of Preventive Cardiology) Despite saying he strongly opposes it, President Biden has no plans to veto a Republican-led measure to end the national COVID-19 emergency; however, the public heal...

U.S. Study Backs 'Helper' Virus Theory in Kids' Mystery Hepatitis Cases
https://www.medpagetoday.com/infectiousdisease/hepatitis/103805

Mar 31st, 2023 - Genotyping results from blood samples of U.S. children with severe acute hepatitis of unknown cause support prior research suggesting that adeno-associated virus 2 (AAV2) along with a "helper" virus may be to blame for last year's global outbreak. In 13 of 14 mystery hepatitis cases (93%), blood samples turned up positive for AAV2 -- a virus not previously recognized as pathogenic, and which re...

Study: Long COVID could involve factors other than SARS-CoV-2 infection
https://www.cidrap.umn.edu/covid-19/study-long-covid-could-involve-factors-other-sars-cov-2-infection
CIDRAP - Center for Infectious Disease Research and Policy; Schnirring L.

Mar 31st, 2023 - Researchers who compared rates of long COVID symptoms in young people with and without a history of mild SARS-CoV-2 infection found prevalence was equally high in the control group, suggesting contributions of other factors. Researchers from Norway using a prospective cohort study design examined patients ages 12 to 25 from two counties who were enrolled between Dec 24, 2020 and May 18, 2021...

Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2802893
JAMA Network Open; Selvakumar J, Havdal LB et. al.

Mar 31st, 2023 - Post–COVID-19 condition (PCC) is characterized by the persistence of symptoms such as fatigue, dyspnea, and what is commonly referred to as “brain fog” occurring 3 months or longer after infection with SARS-CoV-2.1 The prevalence remains uncertain, with a review of PCC symptoms in children and adolescents reporting fatigue rates between 3% and 87%, whereas a meta-analysis reported the confidenc...

Progressive Primary Cutaneous Nocardiosis in an Immunocompetent Patient
https://www.mdedge.com/dermatology/article/262148/infectious-diseases/progressive-primary-cutaneous-nocardiosis
Qian Yu, MD, Jinfeng Song, MD et. al.

Mar 30th, 2023 - To the Editor: The organisms of the genus Nocardia are gram-positive, ubiquitous, aerobic actinomycetes found worldwide in soil, decaying organic material, and water. 1 The genus Nocardia includes more than 50 species; some species, such as Nocardia asteroides, Nocardia farcinica, Nocardia nova, and Nocardia brasiliensis, are the cause of nocardiosis in humans and animals.

Real-world study compares benefits for patients with migraine of mAb against CGRP and its receptor
https://www.mdedge.com/migraine-icymi/article/262131/headache-migraine/real-world-study-compares-benefits-patients-migraine

Mar 30th, 2023 - Key clinical point: Both types of anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAb), those against CGRP ligand (anti-CGRP) and those against CGRP receptor (anti-CGRP-R), showed benefits as preventive treatments for migraine; however, the proportion of anti-CGRP super responders was higher. Major finding: Patients receiving anti-CGRP vs anti-CGRP-R had a significantly lower.

Migraine: Identifying clinical traits of super-responders vs non-responders to CGRP-R mAb
https://www.mdedge.com/migraine-icymi/article/262129/headache-migraine/migraine-identifying-clinical-traits-super

Mar 30th, 2023 - Key clinical point : Clinical characteristics differed significantly among patients with migraine who experienced ≥75% (super-responders [SR]) vs ≤25% (non-responders [NR]) reduction in monthly headache days in the third month after initiating prophylactic treatment with calcitonin gene-related peptide receptor (CGRP-R) monoclonal antibodies (mAb). Major finding: SR vs NR were more likely to re.

Benign paroxysmal positional vertigo associated with higher risk for migraine
https://www.mdedge.com/migraine-icymi/article/262127/headache-migraine/benign-paroxysmal-positional-vertigo-associated

Mar 30th, 2023 - Key clinical point: Patients with benign paroxysmal positional vertigo (BPPV) are at a higher risk for migraine diagnosis, with female sex, hyperlipidemia, and anxiety being significant risk factors for migraine among patients with BPPV. Major finding: In 11 years of follow-up, 1.

Intranasal zavegepant shows potential as an effective treatment option for acute migraine
https://www.mdedge.com/migraine-icymi/article/262122/headache-migraine/intranasal-zavegepant-shows-potential-effective

Mar 30th, 2023 - Key clinical point: Zavegepant nasal spray was effective in the acute treatment of migraine, with favorable tolerability and safety profiles. Major finding: At 2 hours post-dose, higher proportions of patients treated with zavegepant vs placebo were free from pain (risk difference 8.

Pandemic Jump in ED Visits for Firearm Injuries Continued Into 2022
https://www.medpagetoday.com/emergencymedicine/emergencymedicine/103796

Mar 30th, 2023 - Emergency department (ED) visits for firearm injuries increased substantially during the COVID-19 pandemic, CDC researchers said. Compared with 2019, the average number of weekly ED visits for firearm injury was 37% higher in 2020, 36% higher in 2021, and 20% higher in 2022, reported Marissa Zwald, PhD, of the CDC's National Center for Injury Prevention and Control, and colleagues. There was a ...

Mucus plugging phenotype associated with adverse features
https://www.mdedge.com/chestphysician/article/262115/asthma/mucus-plugging-phenotype-associated-adverse-features
Walter Alexander, MDedge News

Mar 30th, 2023 - In a real-life clinic setting study aimed at determining phenotypic associations of mucus plugging in moderate to severe asthma patients, those with mucus plugging had worse lung function, more frequent severe exacerbations needing oral corticosteroids, and higher T2 biomarkers. Rory Chan, MBChB, of the University of Dundee (Scotland) and colleagues found conversely that the presence of these f.

Early treatment considerations in RA, April 2023
https://www.mdedge.com/rheumatology/article/262114/rheumatoid-arthritis/early-treatment-considerations-ra-april-2023
Arundathi Jayatilleke, MD

Mar 30th, 2023 - In evaluating the importance of early aggressive treatment of rheumatoid arthritis (RA), we often look at prognostic factors for severe disease, such as seropositivity, elevated inflammatory markers, and erosions. Eberhard and colleagues looked at the relationship between damage as seen on radiography (including erosions and joint space narrowing) and pain and disability in early RA using an in.

Surgical management of borderline ovarian tumors, part 1
https://www.mdedge.com/obgyn/article/262111/gynecologic-cancer/surgical-management-borderline-ovarian-tumors-part-1
Katherine Tucker, MD

Mar 29th, 2023 - Borderline ovarian tumors (BOTs) are estimated to comprise 10%-15% of all epithelial tumors of the ovary. They are characterized by their behavior, which falls somewhere between benign ovarian masses and frank carcinomas.